Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The tissue injury and inflammation microenvironment is a complex, multi-cellular milieu consisting of immune cells, stromal cells, and a diverse array of signaling molecules such as cytokines and chemokines (Medzhitov, Nature, 2008). This environment is initiated by damage-associated molecular patterns (DAMPs) or pathogen-associated molecular patterns (PAMPs) that trigger an innate immune response to contain injury and initiate repair (Chen & Nuñez, Nature Reviews Immunology, 2010). While essential for host defense and wound healing, a persistent or dysregulated inflammatory microenvironment is a key driver of chronic diseases, including fibrosis, autoimmune disorders, and the progression of various cancers (Hanahan & Weinberg, Cell, 2011). Therapeutic intervention typically involves targeting specific nodes within this network, such as the TNF-alpha or IL-6 pathways, rather than the environment as a whole (Neurath, Nature Reviews Immunology, 2014). Monitoring this microenvironment often relies on systemic biomarkers like C-reactive protein or local cytokine profiling to assess the state of inflammation and response to treatment (Gabay & Kushner, New England Journal of Medicine, 1999). Because this is a physiological state rather than a single molecular target, drug development focuses on modulating the balance of pro- and anti-inflammatory factors to restore tissue homeostasis.
Modulation of the inflammatory milieu through the inhibition of specific cytokines, chemokines, or immune cell signaling pathways to resolve inflammation and promote tissue repair.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tissue injury and inflammation microenvironment.